Friday, June 15th, 2018
FDA Approves Two Generic Medications for Opioid Dependence Treatment
FDA Approves Two Generic Medications for Opioid Dependence Treatment Mylan Technologies Inc. and Dr. Reddy’s Laboratories SA have received the go-ahead to market buprenorphine and naloxone sublingual film. These...
Read More